Volume 4, Number 8 (September 2006)

418

Conference Schedule

full text

54 kb

421

Educational Program Abstracts

full text

121 kb

429

Scientific Abstracts

full text

150 kb

Bench to Bedside

365

Palliation of Malignant Dysphagia in Esophageal Cancer: A Literature-Based Review
Milind Javle, MD, Sikander Ailawadhi, MD, Gary Y. Yang, MD, Chukwumere E. Nwogu, MD, Michael D. Schiff, MD, FACP, and Hector R. Nava, MD

Roswell Park Cancer Institute and State University of New York at Buffalo, Buffalo, New York

abstract

full text

238 kb

PEER VIEWPOINTS
Choosing the Correct Modality for the Treatment of Dysphagia in the Patient With Esophageal Cancer
Bruce D. Minsky, MD, Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York

full text

48 kb

Dysphagia: We Can Relieve This Symptom
Susan Urba, MD, Division of Hematology/Oncology, University of Michigan Medical Center, Ann Arbor

full text

54 kb

381

Prevention and Management of Arm Lymphedema in the Patient With Breast Cancer
Mehra Golshan, MD, and Barbara Smith, MD, PhD

Department of Surgery, Brigham and Women’s Hospital and the Dana-Farber Cancer Institute, Harvard Medical School, and Comprehensive Breast Health Center, Massachusetts General Hospital, Boston, Massachusetts

abstract

full text

146 kb

PEER VIEWPOINTS
Breast Cancer Treatment-Related Lymphedema—A Continuing Problem
Sheila H. Ridner, PhD, RN, Vanderbilt University School of Nursing, Nashville, Tennessee

full text

63 kb

Current Issues in the Management of Lymphedema in Breast Cancer Patients
Ian S. Dayes, MD, MSc, FRCPC, Juravinski Cancer Center, McMaster University, Hamilton, Ontario, Canada

full text

58 kb

Quality-of-Life Outcomes

396

Validation of a Self-Reported Neurotoxicity Scale in Patients With Operable Colon Cancer Receiving Oxaliplatin
Jacek A. Kopec, PhD, Stephanie R. Land, PhD, Reena S. Cecchini, MSc, Patricia A. Ganz, MD, David Cella, PhD, Joseph P. Costantino, PhD, H. Samuel Wieand, PhD, Roy E. Smith, MD, J. Philip Kuebler, MD, and Norman Wolmark, MD

University of British Columbia, Vancouver, Canada; National Surgical Adjuvant Breast and Bowel Project Biostatistical Center, Pittsburgh, Pennsylvania; Department of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania; the Schools of Medicine and Public Health and the Jonsson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles; Center on Outcomes, Research, and Education, Northwestern University, Chicago, Illinois; and the Clinical Community Oncology Program, Columbus, Ohio

abstract

full text

230 kb

397

The Modified Total Neuropathy Score: A Clinically Feasible and Valid Measure of Taxane-Induced Peripheral Neuropathy in Women With Breast Cancer
Meredith A. Wampler, PT, DPTSc, Christine Miaskowski, RN, PhD, Kate Hamel, PhD, Nancy Byl, PT, PhD, Hope Rugo, MD, and Kimberly S. Topp, PT, PhD

University of California, San Francisco and San Francisco State University, San Francisco, California

abstract

full text

193 kb

PEER VIEWPOINT
Chemotherapy-Induced Peripheral Neuropathy: A Need for Standardization in Measurement
Beth Dunlap, BA, and Judith A. Paice, PhD, RN, Northwestern University; Feinberg School of Medicine, Chicago, Illinois

full text

68 kb

Original Research

403

Combination Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy: Palonosetron, Dexamethasone, and Aprepitant
Thomas Grote, MD, Julio Hajdenberg, MD, Alan Cartmell, MD, Susan Ferguson, MD, Angela Ginkel, and Veena Charu, MD

Derrick L. Davis Forsyth Regional Cancer Center, Winston-Salem, North Carolina; M. D. Anderson Cancer Center, Orlando, Florida; Comprehensive Blood and Cancer Center, Bakersfield, California; Cooper Green Hospital, Birmingham, Alabama; MGI PHARMA, INC., Bloomington, Minnesota; Pacific Cancer Center Medical Center, Anaheim, California

abstract

full text

162 kb

How We Do It

411

Selecting Antiepileptic Drugs for Symptomatic Patients With Brain Tumors
Diane Thompson, MD, Junji Takeshita, MD, Todd Thompson, MD, and Meagan Mulligan, BA

Cancer Center Program, The Queen’s Medical Center, Honolulu, Hawaii; John A. Burns School of Medicine, Honolulu,Hawaii; Hawaii Neurosurgery Group, Honolulu. University of Hawaii, Honolulu

full text

149 kb

Observations

409

IAHPC Issues List of Essential Palliative Care Drugs

full text

49 kb

IAHPC list of essential medicines

52 kb

© 2006 Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without written permission from the publisher.

The opinions expressed herein are those of the authors or advertisers. The authors, editors, and publishers make every effort to ensure that no inaccurate or misleading data, opinion, or statement is published in this journal and that drug names, dosages, and recommendations are accurate. However, readers should confirm all dosage schedules against the manufacturer’s package information data. The Publisher, Editorial Board, and their employees accept no liability whatsoever for the consequences of any inaccurate or misleading data, opinion, or statement.